Karyopharm, Zogenix, Heron, Chiasma On The Radar Ahead Of FDA Decisions
June 21, 2020 at 18:53 PM EDT
Biotech stocks rebounded along with the broader market in the week ended June 19. The week was a busy one from the perspective of PDUFA dates, with the FDA issuing approvals for Merck & Co., Inc. and Novartis AG, among others.
